Sumitra Deb

4.6k total citations
79 papers, 3.5k citations indexed

About

Sumitra Deb is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Sumitra Deb has authored 79 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 41 papers in Molecular Biology and 16 papers in Biotechnology. Recurrent topics in Sumitra Deb's work include Cancer-related Molecular Pathways (46 papers), Cancer Research and Treatments (15 papers) and Epigenetics and DNA Methylation (14 papers). Sumitra Deb is often cited by papers focused on Cancer-related Molecular Pathways (46 papers), Cancer Research and Treatments (15 papers) and Epigenetics and DNA Methylation (14 papers). Sumitra Deb collaborates with scholars based in United States, United Kingdom and France. Sumitra Deb's co-authors include Mark A. Subler, P Tegtmeyer, Daniel W. Martin, Swati Palit Deb, A L DeLucia, Doris Brown, Andrew Koff, Catherine A. Vaughan, Raquel Muñoz and Mariano J. Scian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Sumitra Deb

78 papers receiving 3.4k citations

Peers

Countries citing papers authored by Sumitra Deb

Since Specialization

Citations

This map shows the geographic impact of Sumitra Deb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumitra Deb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumitra Deb more than expected).

Fields of papers citing papers by Sumitra Deb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumitra Deb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumitra Deb. The network helps show where Sumitra Deb may publish in the future.

Co-authorship network of co-authors of Sumitra Deb

This figure shows the co-authorship network connecting the top 25 collaborators of Sumitra Deb. A scholar is included among the top collaborators of Sumitra Deb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumitra Deb. Sumitra Deb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TMB as a predictive biomarker for ICI response in TNBC: current evidence and future directions for augmented anti-tumor responses 2025 ·Clinical and Experimental Medicine ·Rajdeep Das, Sumitra Deb, P.K. Suresh	0
2	Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells 2017 ·Molecular Oncology ·Catherine A. Vaughan, Shilpa Singh, Steven R. Grossman, Brad E. Windle, Swati Palit Deb, Sumitra Deb, (unknown), (unknown)	14
3	Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination 2016 ·Molecular Cancer Research ·(unknown), Ian M. Love, Priyadarshan K. Damle, Nitai D. Mukhopadhyay, Swati Palit Deb, Sumitra Deb, Steven R. Grossman	14
4	Lung Cancer Stem Cells, p53 Mutations and MDM2 2014 ·Sub-cellular biochemistry ·(unknown), Swati Palit Deb, Sumitra Deb, Raj R. Rao	20
5	ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation 2013 ·Clinical Cancer Research ·(unknown), Sajjad Muhammad, Elizabeth Rosenberg, Jason M. Beckta, Nicholas C.K. Valerie, Mary Tokarz, Bret R. Adams, Alison F. Wagner, Ashraf Khalil, Donna Gilfor, Sarah E. Golding, Sumitra Deb, (unknown), Alan Lau, Mark J. O’Connor, Kevin S. Choe, Luis F. Parada, Sang Kyun Lim, Nitai D. Mukhopadhyay, Kristoffer Valerie	150
6	The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing 2013 ·Nucleic Acids Research ·(unknown), Sandeep K. Singh, Catherine A. Vaughan, Nitai D. Mukhopadhyay, (unknown), B E Windle, Sumitra Deb	28
7	Allele specific gain-of-function activity of p53 mutants in lung cancer cells 2012 ·Biochemical and Biophysical Research Communications ·Catherine A. Vaughan, (unknown), Isabella Pearsall, Shilpa Singh, Brad E. Windle, W. Andrew Yeudall, Swati Palit Deb, Sumitra Deb, (unknown), (unknown)	20
8	Measurement of Chemosensitivity and Growth Rate in p53 Expressing Cells 2012 ·Methods in molecular biology ·Mahesh Ramamoorthy, Catherine A. Vaughan, Sumitra Deb, Swati Palit Deb	1
9	Gain-of-Function Activity of Mutant p53 in Lung Cancer through Up-Regulation of Receptor Protein Tyrosine Kinase Axl 2012 ·Genes & Cancer ·Catherine A. Vaughan, Sandeep K. Singh, B E Windle, W. Andrew Yeudall, (unknown), (unknown), Sumitra Deb	55
10	ChIP Sequencing to Identify p53 Targets 2012 ·Methods in molecular biology ·Catherine A. Vaughan, Brad Windle, Sumitra Deb	3
11	Use of the DNA Fiber Spreading Technique to Detect the Effects of Mutant p53 on DNA Replication 2012 ·Methods in molecular biology ·(unknown), Sumitra Deb, Swati Palit Deb	12
12	Identification of Novel Mutant p53 Interacting Proteins by Proteomic Analysis 2012 ·Methods in molecular biology ·Sumitra Deb, Paul R. Graves	2
13	Human Oncoprotein MDM2 Up-regulates Expression of NF- B2 Precursor p100 Conferring a Survival Advantage to Lung Cells 2011 ·Genes & Cancer ·Catherine A. Vaughan, Lathika Mohanraj, Sandeep K. Singh, Catherine I. Dumur, Mahesh Ramamoorthy, Carleton T. Garrett, B E Windle, W. Andrew Yeudall, Sumitra Deb, Swati Palit Deb	13
14	MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle 2009 ·Molecular Cancer Research ·(unknown), Mahesh Ramamoorthy, Lathika Mohanraj, Sumitra Deb, Swati Palit Deb	21
15	Hetero-oligomerization does not compromise ‘gain of function’ of tumor-derived p53 mutants 2002 ·Oncogene ·(unknown), Mariano J. Scian, (unknown), Wěi Li, (unknown), Abhay Sankar Chakraborti, Swati Palit Deb, Sumitra Deb	23
16	`Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain 1998 ·Oncogene ·Árpád Lányi, (unknown), (unknown), John Ludes-Meyers, Mark A. Subler, Sumitra Deb	74
17	Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter 1995 ·Molecular and Cellular Biology ·(unknown), Doris Brown, Sumitra Deb, Swati Palit Deb, (unknown), (unknown)	103
18	Analysis of the DNA-Binding Domain of the HSV-1 Origin-Binding Protein 1994 ·Virology ·Daniel W. Martin, Raquel Muñoz, David J. Oliver, Mark A. Subler, Sumitra Deb	23
19	Domain Structure of the Simian Virus 40 Core Origin of Replication 1986 ·Molecular and Cellular Biology ·Sumitra Deb, A L DeLucia, (unknown), Andrew Koff, P Tegtmeyer	146
20	ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma. 1985 ·The Journal of Experimental Medicine ·M. V. Viola, Frank B. Fromowitz, (unknown), Sumitra Deb, Jeffrey Schlom	148

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact